Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice

Author: Machlenkin Arthur   Azriel-Rosenfeld Ronit   Volovitz Ilan   Vadai Ezra   Lev Avital   Paz Adrian   Goldberger Ofir   Reiter Yoram   Tzehoval Esther   Benhar Itai   Eisenbach Lea  

Publisher: Springer Publishing Company

ISSN: 0340-7004

Source: Cancer Immunology, Immunotherapy, Vol.56, Iss.2, 2007-02, pp. : 217-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content